Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro

Published:2014-06-20 Issue:3 Volume:350 Page:552-562
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Xu Weijia,Shao Xinghua,Tian Lei,Gu Leyi,Zhang Minfang,Wang Qin,Wu Bei,Wang Ling,Yao Jufang,Xu Xiaoping,Mou Shan,Ni Zhaohui

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury

2. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome

3. The effect of Radix astragali in treating patients with proteinuria;Chen;Lishizhen Med Materia Medica Res,2001

4. Klotho Inhibits Transforming Growth Factor-β1 (TGF-β1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice

5. Gobe GC Axelsen RA (1987) Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273–281.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomic study of kidney in a mouse model with urine flow obstruction;Scientific Reports;2024-08-05

2. Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis;Chinese Journal of Integrative Medicine;2024-06-08

3. Identification of novel therapeutic targets for jaranol alleviating cognitive impairment in db/db mice;2024-05-03

4. Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy;Cells;2023-07-04

5. Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney;Frontiers in Pharmacology;2023-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3